Baird cut their target price on shares of DexCom from $115.00 to $105.00 and set an “outperform” rating ... The company’s revenue for the quarter was up 12.5% on a year-over-year basis.

Q1 2025 Results Conference Call May 6, 2025 4:30 PM ETCompany ParticipantsBlake Beber - Head, IRSean Saint - President ...

Ken Griffin, the founder of Citadel, is an influential albeit controversial figure in the investment industry. Ken Griffin tasted early success while trading during his college days, and it is safe to ...

Following their prepared remarks, the operator will open up the call for questions ... which is available with Dexcom, G6 and G7 sensor integration in approximately 25 countries.

Q1 2025 Earnings Call Transcript April 30, 2025 Tandem Diabetes Care, Inc. misses on earnings expectations. Reported EPS is $-0.67 EPS, expectations were $-0.6. Susan Morrison – EVP & Chief ...

Kevin Sayer; Chairman of the Board, President, Chief Executive Officer; Dexcom Inc Jereme Sylvain ... Following our prepared remarks, we will open the call up for your questions.

Shares of DexCom jumped over 15% to pace the S&P 500's advancers Friday, a day after the maker of glucose monitoring devices ...

To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume. Dexcom Inc. surged by 16.17 percent on Friday to end at $81.62 apiece ...

In this article, we are going to take a look at where DexCom, Inc. (NASDAQ ... and we cannot afford to drive up the cost of health care for patients, or on the health care system.